RxDoctor Payments Data

Dorothy Miller, MD

Family Medicine · Longview, TXNPI 1922075126

Payments from drug & device makers

$10,084in general payments, 2019–2025

Across 741 payments — averaging $13.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$1K
  • GSK$957
  • Amgen$922
  • Lilly USA, LLC$796
  • AstraZeneca$549
  • plus $4K from 45 others

What the payments were for

  • Food & beverage$10,039100%
  • Education$460%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,084 in reported general payments places this provider in the 90th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$262,371
Medicare patients
299
Services billed
11,729

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide55$66,335
EliquisApixaban64$45,031
JardianceEmpagliflozin44$38,850
MounjaroTirzepatide30$32,624
TrulicityDulaglutide14$15,476
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog18$10,220
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$9,795
Jentadueto XrLinagliptin/Metformin Hcl14$9,044
Breo ElliptaFluticasone/Vilanterol17$6,766
Metoprolol Succinate208$3,552
Nebivolol Hcl25$2,825
Pantoprazole Sodium205$2,823
SynthroidLevothyroxine Sodium46$2,778
Levothyroxine Sodium306$2,767
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen101$2,500

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,410$66,33555 claims
Lilly USA, LLCMounjaro, Trulicity$796$48,10044 claims
Boehringer IngelheimJardiance, Jentadueto Xr$498$47,89458 claims
PfizerEliquis$349$45,03164 claims
GSKTrelegy Ellipta, Breo Ellipta$957$16,56129 claims
AbbVieSynthroid$1,347$2,77846 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Longview

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →